维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Berns EM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	MicroRNAs in ovarian cancer biology and therapy resistance显示文摘	van Jaarsveld MT Helleman J Berns EM Wiemer EA		0，，：	1
2	Oncogone amplification and prognoeis in breast cancer relationship with systernic treament显示文摘	Foekon JA Vanstaveren IL	1995	Gene1995，159，：	1
3	Predictive value ofSRC - 1 for tamoxifen response of recurrent breast cancer显示文摘	Berns EM Van Staveren 1L Klijn JG	1998	Breast Cancer Res Treat1998，48，：	1
4	A large-scale RNAi screen in human cells identifies new components of the p53 pathway显示文摘	BERNS K HIJMANS EM MULLENDERS J	2004	Nature2004，428，：	1
5	Correlation of breast cancer susceptibility loci with patient characteristics, metastasis {ree survival, and mRNA expression of the nearest genes显示文摘	Riaz M Berns EM Sieuwerts AM	2012	Breast Cancer Res Treat2012，13，3：	1
6	Oncogene amplification and prognosis in breast cancer:relationship with systernic treatment显示文摘	Berns EM Foekens JA van Staveren IL	1995	Gene1995，159，1：	1
7	A huge-scale RNAi screen in human cells identifies new comonents of the p53 pathway 显示文摘	Berns K Hijmans EM MuUenders J	2004	Nature2004，428，6981：	1
8	A large-scale RNAi screen in human cells identifies new components of the p53 pathway显示文摘	Berns K Hijmans EM Mullenders J	2004	Nature2004，428，6981：	1
9	A large-scale RNAi screen in human cells identifies new components of the p53 pathway显示文摘	Berns K Hijmans EM Mullenders J	2004	Nature2004，428，6981：	1
10	Is TP53 dysfunction required for BRCAl-associated carcinogenesis? 显示文摘	Schuyer M Berns EM	1999	Mol Cell Endocrinol1999，155，12：	1
11	A large-scale RNAi screen in human cells identifies new components of the p53 pathway显示文摘	Berns K Hijmans EM Mullenders J		0，，6981：	1
12	Expression of urokinase type plasminogen activator(uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors Int 显示文摘	Van der Burg ME Henten-logmans SC Berns EM	1996	Cancer1996，69，6：	1
13	MicroRNAs in ovarian cancer biology and therapy resistance显示文摘	van Jaarsveld MT Helleman J Berns EM	2010	Int J Biochem Cell Biol2010，42，8：	1
14	CYP2C19 * 2 polymorphism is associated with increased survival in breast cancer patients using tamoxifen 显示文摘	Ruiter R Bijl MJ van Schaik RH Berns EM Hofman A Coe- bergh JW	2010	Pharmacogenomics2010，11，10：	1
15	Prognostic factors and response to therapy in breast cancer 显示文摘	Klijn JG Berns EM Foekens JA	1993	Cancer Surv1993，18，：	1
16	A large-scale RNAi screen in human cells identifies new components of the p53 pathway显示文摘	Berns K Hijmans EM Mullenders J	2004	Nature2004，428，6981：	1
17	Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign,borderline,malignant primary and metastatic ovarian tumors Int显示文摘	Henzen-Logmans SC Berns EM	1996	Cancer1996，69，6：	1
18	Alterations in the p53 pathway and prognosis in advanced ovarian cancer:A multi-factorial analysis of the EORTC gynaecological cancer group显示文摘	Green JA Berns EM Coens C	2006	Eur J Cancer2006，42，15：	1
19	Oncogene amplification and prognosis in breast cancer relationship with systemic treament显示文摘	Berns EM Foeken JA Vanstaveren IL	1995	Gene1995，159，：	1
20	c-myc amplification is a better prognostic factor than HEB2/neu amplification in primary breast显示文摘	Berns EM J	1992	Cancer Res1992，52，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示